Clinical Trials Directory

Trials / Completed

CompletedNCT03683914

Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients

Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients: A Randomized Double-Blind Placebo-Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare the effectiveness of vaginal dinoprostone with placebo in minimising the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.

Detailed description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body.Cervical ripening is made possible by the use of medication through different routes.The most commonly used agent is misoprostol,a synthetic prostaglandin E1 (PGE1) analogue that is frequently administered in off-label use in obstetrics and gynaecology for medical abortion, labor induction, endometrial biopsy, dilatation and curettage, intrauterine device insertion, myomectomy, postpartum haemorrhage, and cervical ripening.In contrast, dinoprostone, a natural PGE2, is mostly used in obstetrics for cervical ripening and the stimulation of uterine contractions to induce labor.

Conditions

Interventions

TypeNameDescription
DRUGDinoprostone 3Mg Vaginal Tablet1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the patient 12 hours before the scheduled office diagnostic hysteroscopy.
DRUGplacebo vaginal tablet1 vaginal tablet of placebo inserted by the patient 12 hours before the scheduled office diagnostic hysteroscopy.

Timeline

Start date
2018-09-30
Primary completion
2019-01-30
Completion
2019-02-28
First posted
2018-09-25
Last updated
2019-03-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03683914. Inclusion in this directory is not an endorsement.

Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients (NCT03683914) · Clinical Trials Directory